Additional secondary outcomes
There were no differences between the two groups in mHLA-DR expression or IL-6 concentration. Along these lines, no differences were found between the two groups in lymphocyte count or M-MDSC and IDO activity (Additional file The Kaplan‒Meier curves for overall survival from randomization (day 0) to day 28 are presented in Additional file 